These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9329849)

  • 1. Vaginal drug delivery: the first uterine pass effect.
    Bulletti C; De Ziegler D; Giacomucci E; Polli V; Rossi S; Alfieri S; Flamigni C
    Ann N Y Acad Sci; 1997 Sep; 828():285-90. PubMed ID: 9329849
    [No Abstract]   [Full Text] [Related]  

  • 2. The first uterine pass effect.
    De Ziegler D; Bulletti C; De Monstier B; Jääskeläinen AS
    Ann N Y Acad Sci; 1997 Sep; 828():291-9. PubMed ID: 9329850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted drug delivery in gynaecology: the first uterine pass effect.
    Bulletti C; de Ziegler D; Flamigni C; Giacomucci E; Polli V; Bolelli G; Franceschetti F
    Hum Reprod; 1997 May; 12(5):1073-9. PubMed ID: 9194669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone bioavailability with a progesterone-releasing silicone vaginal ring in IVF candidates.
    Dragonas C; Maltaris T; Binder H; Kat M; Mueller A; Cupisti S; Hoffmann I; Beckmann MW; Dittrich R
    Eur J Med Res; 2007 Jun; 12(6):264-7. PubMed ID: 17666316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of uterine specificity of vaginal progesterone.
    Cicinelli E; Schonauer LM; Galantino P; Matteo MG; Cassetta R; Pinto V
    Hum Reprod; 2000 Jun; 15 Suppl 1():159-65. PubMed ID: 10928427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus.
    Cicinelli E; de Ziegler D
    Hum Reprod Update; 1999; 5(4):365-72. PubMed ID: 10465526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of progesterone are higher in the uterine artery than in the radial artery after vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women.
    Cicinelli E; Cignarelli M; Sabatelli S; Romano F; Schonauer LM; Padovano R; Einer-Jensen N
    Fertil Steril; 1998 Mar; 69(3):471-3. PubMed ID: 9531879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoadhesive tablets for the vaginal delivery of progesterone: in vitro evaluation and pharmacokinetics/pharmacodynamics in female rabbits.
    Hassan AS; Soliman GM; Ali MF; El-Mahdy MM; El-Gindy GEA
    Drug Dev Ind Pharm; 2018 Feb; 44(2):224-232. PubMed ID: 28956650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting.
    Aboud HM; Hassan AH; Ali AA; Abdel-Razik AH
    Drug Deliv; 2018 Nov; 25(1):1328-1339. PubMed ID: 29869515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine contractility: vaginal administration of the beta-adrenergic agonist, terbutaline. Evidence of direct vagina-to-uterus transport.
    Bulletti C; de Ziegler D; de Moustier B; Polli V; Bolelli G; Franceschetti F; Flamigni C
    Ann N Y Acad Sci; 2001 Sep; 943():163-71. PubMed ID: 11594537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments.
    Tavaniotou A; Smitz J; Bourgain C; Devroey P
    Hum Reprod Update; 2000; 6(2):139-48. PubMed ID: 10782572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple pharmacokinetic model linking plasma progesterone concentrations with the hormone released from bovine intravaginal inserts.
    Mariano RN; Turino LN; Cabrera MI; Scándolo DE; Maciel MG; Grau RJ
    Res Vet Sci; 2010 Oct; 89(2):250-6. PubMed ID: 20307896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of natural progesterone vaginal suppository.
    von Eye Corleta H; Capp E; Ferreira MB
    Gynecol Obstet Invest; 2004; 58(2):105-8. PubMed ID: 15192285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of route of administration on progesterone metabolism.
    de Lignieres B; Dennerstein L; Backstrom T
    Maturitas; 1995 Apr; 21(3):251-7. PubMed ID: 7616875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oral micronized progesterone when applied via vaginal route.
    Choavaratana R; Manoch D
    J Med Assoc Thai; 2004 May; 87(5):455-8. PubMed ID: 15222511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy.
    Palagiano A; Bulletti C; Pace MC; DE Ziegler D; Cicinelli E; Izzo A
    Ann N Y Acad Sci; 2004 Dec; 1034():200-10. PubMed ID: 15731312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo.
    Duijkers IJM; Klingmann I; Prinz R; Wargenau M; Hrafnsdottir S; Magnusdottir TB; Klipping C
    Hum Reprod; 2018 Nov; 33(11):2131-2140. PubMed ID: 30265306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micronized progesterone: vaginal and oral uses.
    Simon JA
    Clin Obstet Gynecol; 1995 Dec; 38(4):902-14. PubMed ID: 8616985
    [No Abstract]   [Full Text] [Related]  

  • 19. [Variation in plasma progesterone induced by the vaginal administration of Utrogestan].
    Erny R; Simoncini C; Chastellière N; de Lignères B
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(2):229-34. PubMed ID: 2723354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an injection molded ethylene-vinyl acetate copolymer (EVA) intravaginal insert for the delivery of progesterone to cattle.
    Cappadoro AJ; Luna JA
    Anim Reprod Sci; 2015 Jul; 158():104-8. PubMed ID: 26022232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.